Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, according to data from two European Congress on Obesity abstracts ...

Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.